Lixosicone

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameLixosicone
Drug Alias Name3beta-(4-methoxybenzyloxy)pregn-5-en-20-oneAEF-0117
ClassificationSmall molecules > Steroids
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsMarijuana Abuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAelis FarmaNational Institute On Drug Abuse
China Registration ClassN/A

Develop Information

Active CompaniesAelis FarmaIndivior PLC
Inactive CompaniesNational Institute On Drug Abuse
Active IndicationsMarijuana Abuse
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A